…
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Income before tax | -2.70M | 2.21M | -9.33M | -4.05M | -6.70M |
| Net income | -2.78M | 4.84M | -6.17M | -4.18M | -6.91M |
| Selling general administrative | 5.28M | 5.49M | 47.37M | 32.08M | 28.96M |
| Selling and marketing expenses | - | 3.63M | 2.38M | 0.45M | 0.47M |
| Gross profit | 163.84M | 106.65M | 74.18M | 52.99M | 43.39M |
| Reconciled depreciation | 40.16M | 23.04M | 17.79M | 14.62M | 10.55M |
| Ebit | 15.09M | 17.36M | 2.90M | 4.49M | 2.83M |
| Ebitda | 55.25M | 40.40M | 20.69M | 19.11M | 13.38M |
| Depreciation and amortization | 40.16M | 23.04M | 17.79M | 14.62M | 10.55M |
| Operating income | 15.09M | 17.36M | 2.90M | 4.49M | 2.83M |
| Other operating expenses | 206.56M | 122.06M | 95.72M | 67.19M | 57.81M |
| Interest expense | 6.61M | 2.08M | 1.85M | 1.85M | 1.92M |
| Tax provision | 0.09M | -1.90M | -3.15M | 0.13M | 0.20M |
| Interest income | - | - | - | 0.00M | 0.03M |
| Net interest income | -6.61M | -2.08M | -1.99M | -2.06M | -3.22M |
| Income tax expense | 0.09M | -1.90M | -3.15M | 0.13M | 0.20M |
| Total revenue | 221.74M | 139.86M | 102.35M | 73.03M | 61.16M |
| Total operating expenses | 148.67M | 88.85M | 67.54M | 47.15M | 40.04M |
| Cost of revenue | 57.90M | 33.21M | 28.17M | 20.04M | 17.77M |
| Total other income expense net | -11.27M | -15.14M | -12.23M | -8.54M | -9.53M |
| Discontinued operations | - | - | - | -1.16M | 1.75M |
| Net income from continuing ops | -2.78M | 4.84M | -6.17M | -4.18M | -6.91M |
| Net income applicable to common shares | - | 4.84M | -6.17M | -6.75M | -7.39M |
| Breakdown | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Total assets | 246.86M | 247.41M | 132.21M | 108.57M | 71.82M |
| Intangible assets | 67.95M | - | 28.89M | 14.87M | 5.56M |
| Other current assets | 6.91M | - | 1.05M | 1.43M | 0.55M |
| Total liab | 140.06M | 136.29M | 52.67M | 49.95M | 43.68M |
| Total stockholder equity | 107.19M | 111.11M | 79.55M | 58.62M | 28.14M |
| Deferred long term liab | - | - | - | 0.42M | 0.77M |
| Other current liab | 6.05M | - | -18.67M | 5.58M | 6.18M |
| Common stock | - | - | 214.25M | 202.83M | 167.77M |
| Capital stock | 0.00M | - | 214.25M | 202.83M | 167.77M |
| Retained earnings | -170.57M | - | -161.02M | -165.86M | -165.92M |
| Other liab | - | - | - | 0.13M | 3.80M |
| Good will | 50.73M | - | 28.21M | 12.46M | 3.88M |
| Other assets | -0.12M | - | 0.09M | 0.50M | 0.86M |
| Cash | 16.17M | 17.21M | 8.52M | 34.61M | 29.12M |
| Total current liabilities | 60.85M | 60.57M | 41.74M | 32.74M | 24.30M |
| Current deferred revenue | 3.57M | - | 3.04M | 7.34M | 4.39M |
| Net debt | 83.63M | -17.21M | 18.05M | -7.56M | -6.26M |
| Short term debt | 21.92M | - | 15.63M | 9.97M | 6.33M |
| Short long term debt | 16.05M | - | 12.33M | 6.99M | 4.30M |
| Short long term debt total | 99.80M | - | 26.56M | 27.05M | 22.86M |
| Other stockholder equity | 277.76M | - | 26.32M | 21.66M | 16.32M |
| Property plant equipment | - | - | 33.50M | 23.51M | 22.24M |
| Total current assets | 73.05M | 65.43M | 41.54M | 57.23M | 45.12M |
| Long term investments | 1.31M | - | - | - | - |
| Net tangible assets | - | - | 22.45M | 31.29M | 25.03M |
| Net receivables | 29.12M | 48.22M | 16.38M | 11.94M | 9.06M |
| Long term debt | 64.60M | - | 3.73M | 12.30M | 13.32M |
| Inventory | 20.85M | - | 15.59M | 9.25M | 6.39M |
| Accounts payable | 29.31M | 60.57M | 41.74M | 9.84M | 7.41M |
| Accumulated other comprehensive income | - | - | - | - | 9.97M |
| Common stock total equity | - | - | - | - | 167.77M |
| Non currrent assets other | 0.06M | 128.57M | 0.09M | 0.50M | 0.64M |
| Non current assets total | 173.92M | 181.97M | 90.68M | 51.34M | 26.70M |
| Capital lease obligations | 19.15M | - | 10.50M | 7.76M | 5.25M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Investments | -82.83M | -42.49M | -17.84M | -7.90M | 1.77M |
| Change to liabilities | - | 2.93M | 0.85M | 2.86M | 1.24M |
| Total cashflows from investing activities | - | -42.49M | -17.84M | -10.57M | 3.94M |
| Net borrowings | - | -3.72M | -13.89M | -17.45M | -9.26M |
| Total cash from financing activities | 50.87M | -9.85M | 3.91M | 13.95M | -3.82M |
| Change to operating activities | - | 0.45M | -0.86M | 0.15M | -0.32M |
| Net income | -2.78M | 4.84M | -6.17M | -5.05M | -5.58M |
| Change in cash | 8.69M | -26.10M | 5.38M | 19.52M | 6.44M |
| Begin period cash flow | 8.52M | 34.61M | 29.23M | 9.60M | 3.27M |
| End period cash flow | 17.21M | 8.52M | 34.61M | 29.12M | 9.71M |
| Total cash from operating activities | 40.54M | 26.34M | 18.69M | 13.17M | 8.39M |
| Issuance of capital stock | 27.01M | - | 0.00M | 19.45M | 3.13M |
| Depreciation | - | 23.04M | 17.79M | 14.62M | 10.55M |
| Other cashflows from investing activities | - | - | - | - | 4.45M |
| Change to inventory | - | -2.42M | -0.04M | -1.77M | 0.64M |
| Change to account receivables | - | -0.20M | -8.82M | -5.14M | -5.16M |
| Other cashflows from financing activities | 63.42M | 10.79M | 17.80M | 7.54M | 9.91M |
| Change to netincome | - | -2.54M | 15.82M | 10.78M | 7.83M |
| Capital expenditures | 6.79M | 8.97M | 5.05M | 0.09M | 1.36M |
| Change in working capital | -1.95M | 0.76M | -8.88M | -4.66M | -3.82M |
| Stock based compensation | - | 5.49M | 4.95M | 0.17M | 1.56M |
| Other non cash items | 45.27M | -5.88M | 14.80M | 1.49M | 1.39M |
| Free cash flow | 33.75M | 17.38M | 13.65M | 13.08M | 7.03M |
Sector: Healthcare Industry: Medical Distribution
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MCK McKesson Corporation |
2.41 0.22% |
1082.20 | 24.45 | 20.41 | 0.26 | 5.04 | 0.27 | 15.03 |
| COR Cencora Inc. |
1.29 0.37% |
351.17 | 24.22 | 16.39 | 0.19 | 20.41 | 0.21 | 13.72 |
| CAH Cardinal Health Inc |
2.00 0.72% |
279.45 | 29.48 | 17.92 | 0.20 | 16.07 | 0.22 | 15.67 |
| HSIC Henry Schein Inc |
-0.06 0.07% |
88.36 | 25.89 | 15.08 | 0.72 | 3.14 | 1.00 | 13.43 |
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
| Name | Title | Year Born |
|---|---|---|
| Mr. Gregory J. Crawford | Chairman, Pres & CEO | NA |
| Mr. Hardik Mehta | Chief Financial Officer | NA |
| Mr. Jerry Kirn | VP of Operations | NA |
| Mr. David Bachelder | Exec. VP of Operations | NA |
| Mr. William Todd Zehnder | Chief Strategy Officer & Investor Relations | 1975 |
| Cole Stevens | VP of Corp. Devel. & VP of Investor Relations | NA |
| Leslie Becker | Exec. VP of Bus. Devel. | NA |
| Dr. William Dana Frazier M.D. | Chief Medical Officer | 1958 |
| Mr. Mark Miles | VP of Information Technology | NA |
| Mr. Thomas W. Roehrig | Exec. VP of Fin. | 1966 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.